ePiggyBac: A Novel Tool For Reprogramming Human Cells
The Rockefeller University
posted on 01/26/2010
Human embryonic stem cells (hESCs) hold immense potential for regenerative medicine, drug screens and basic research for human diseases. The ability to fully tap into the therapeutic potential of hESCs is limited by several factors, including difficulties in generating transgenic hESC lines, lack of reliable reporter systems for gain or loss of function. The present gene targeting techniques for hESCs are often limited to small cargo size and one expression cassette per insertion. These existing systems result in the stable integration of transfer vectors with hESCs, resulting in exogenous inserts in the genome and irreversible genome modifications, which in turn may lead to higher predisposition towards tumorigenesis or uncontrolled cell behavior. To overcome these limitations, our scientists have developed an ePiggyBac system, by engineering PiggyBac transposons. This system is capable of effectively delivering multigene inserts in hESCs in a reversible manner. In addition, it is also able to carry insulators, inducible expression cassettes, and short hairpin RNAs for gain- and loss- of-function approaches. Hence, the ePiggyBac is a powerful research tool for the stem cell field, and can be used to develop clinical-grade pluripotent cell lines.
Suggested Uses
Advantages
File Number: RU 878
Other Information: -Lacoste, et al. (2009), Cell Stem Cell: 5, 332-342. -Patent pending
This innovation currently is not available for online licensing. Please contact Nidhi Sabharwal at The Rockefeller University for more information.
Find more innovations
